EVANS HANDEL 4
4 · ALLERGAN INC · Filed Apr 27, 2005
Insider Transaction Report
Form 4
ALLERGAN INC(AGN)
EVANS HANDEL
Director
Transactions
- Award
Phantom Stock Units
2005-04-25$72.98/sh+13.7$1,000→ 27,742.19 total→ Common Stock (0 underlying) - Award
Phantom Stock Units
2005-04-26$73.01/sh+27.39$2,000→ 27,783.28 total→ Common Stock (0 underlying) - Award
Nonemployee Director Stock Option (Right to Buy)
2005-04-26+2,500→ 2,500 totalExercise: $72.98From: 2006-04-26Exp: 2015-04-26→ Common Stock (2,500 underlying)
Footnotes (5)
- [F1]The per share exercise price is the closing price of Allergan common stock as of April 25, 2005, rounded upwards to three decimals.
- [F2]Option is fully vested and exercisable on the one year (1) year anniversary of its grant.
- [F3]Converts to common stock on a 1-for-1 basis.
- [F4]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for meeting fees.
- [F5]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. director.